Drug Shortage Report for MINT-IRBESARTAN
| Report ID | 80803 |
| Drug Identification Number | 02423006 |
| Brand name | MINT-IRBESARTAN |
| Common or Proper name | Irbesartan |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IRBESARTAN |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 count bottles |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-04-08 |
| Estimated end date | 2020-06-30 |
| Actual end date | 2021-06-22 |
| Shortage status | Resolved |
| Updated date | 2021-07-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2021-07-12 | French | Compare |
| v10 | 2021-07-12 | English | Compare |
| v9 | 2020-01-27 | French | Compare |
| v8 | 2020-01-27 | English | Compare |
| v7 | 2019-07-04 | French | Compare |
| v6 | 2019-07-04 | English | Compare |
| v5 | 2019-06-15 | French | Compare |
| v4 | 2019-06-15 | English | Compare |
| v3 | 2019-04-09 | English | Compare |
| v2 | 2019-04-08 | French | Compare |
| v1 | 2019-04-08 | English | Compare |
Showing 1 to 11 of 11